EP3518912
DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.9.2017:
30.12.2020:
17781051.2
:
27.9.2037
:
DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA
28.9.2017
30.12.2020
:
Nashpharm:
18 avenue Bellevue, 06270 Villeneuve Loubet, FR
:
LARUELLE, Claude:
06270 Villeneuve Loubet, FR
:
BONNAFOUS, Ludovic:
06370 Mouans Sartoux, FR
:
1659435:
30.9.2016:
FR
:
EP2017074703:
28.9.2017
:
A61K 31/155, A61K 31/192, C07C 279/26, C07C 323/62, A61K 9/00, A61P 1/16, A61P 3/06, A61P 3/10, A61P 3/04, A61P 9/00